Perioperative Mortality: A Retrospective Cohort Study of 75,446 Noncardiac Surgery Patients
- PMID: 39263428
- PMCID: PMC11387539
- DOI: 10.1016/j.mayocpiqo.2024.07.002
Perioperative Mortality: A Retrospective Cohort Study of 75,446 Noncardiac Surgery Patients
Abstract
Objective: To evaluate whether major adverse cardiac events (MACE) continue to be a major causative factor for mortality after noncardiac surgery.
Patients and methods: We performed retrospective study of 75,410 adult noncardiac surgery patients at Mayo Clinic Rochester, between January 1, 2016, and May 4, 2018. Electronic medical records were reviewed and data collected on all deaths within 30 days (n=692 patients) of surgery. The incidence of death due to MACE was calculated.
Results: Postoperative MACE occurred in 150 patients (21.4 events per 10,000 patients; 95% CI, 18.2-25.2 events per 10,000 patients) with most occurring within 3 days of surgery (n=113). Postoperative MACE events were associated with atrial fibrillation with rapid rate response in 25 patients (16.7%), sepsis in 15 patients (10%), and bleeding in 15 patients (10%). There were 12 intraoperative deaths of which 9 were due to exsanguination (75%) and the remaining 3 (25%) due to cardiac arrest. Of the 56 deaths on the first 24 hours after surgery, 7 were due to hemorrhage, 17 due to cardiovascular causes, 20 due to sepsis, and 7 due to neurologic disease. The leading cause of total death over 30 days postoperatively was sepsis (28%), followed by malignancy (27%), cardiovascular disease (12%) neurologic disease (12%), and hemorrhage (5%).
Conclusion: MACE was not the leading cause of death both intraoperatively and postoperatively.
© 2024 The Authors.
Conflict of interest statement
The authors report no competing interests.
Figures
Similar articles
-
EVALUATION OF PERIOPERATIVE HIGH-SENSITIVE CARDIAC TROPONIN I AS A PREDICTIVE BIOMARKER OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AFTER NONCARDIAC SURGERY.Rev Invest Clin. 2020;72(2):110-118. doi: 10.24875/RIC.19002888. Rev Invest Clin. 2020. PMID: 32284625
-
Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.JAMA Intern Med. 2014 Mar;174(3):336-44. doi: 10.1001/jamainternmed.2013.11349. JAMA Intern Med. 2014. PMID: 24247428
-
One-year Outcomes after Discharge from Noncardiac Surgery and Association between Predischarge Complications and Death after Discharge: Analysis of the VISION Prospective Cohort Study.Anesthesiology. 2024 Jan 1;140(1):8-24. doi: 10.1097/ALN.0000000000004763. Anesthesiology. 2024. PMID: 37713506
-
Outcome of Organ Dysfunction in the Perioperative Period.Anesth Analg. 2021 Aug 1;133(2):393-405. doi: 10.1213/ANE.0000000000005603. Anesth Analg. 2021. PMID: 34081049 Review.
-
Postoperative elevated cardiac troponin levels predict all-cause mortality and major adverse cardiovascular events following noncardiac surgery: A dose-response meta-analysis of prospective studies.J Clin Anesth. 2023 Nov;90:111229. doi: 10.1016/j.jclinane.2023.111229. Epub 2023 Aug 11. J Clin Anesth. 2023. PMID: 37573706 Review.
References
LinkOut - more resources
Full Text Sources